Friday, August 3, 2018

Enterprise Refills the Project Hopper in the Second Quarter

The first quarter of 2018 was a strangely quiet one for oil and gas midstream operator Enterprise Products Partners (NYSE:EPD). Typically, the company announces at least a couple of new projects each quarter to grow the business and fuel its distribution to shareholders. Apparently, it was saving most of its project announcements for this past quarter as management added $600 million to its capital expenditure guidance for the year.�

Let's take a look at Enterprise's most recent earnings results and some of the new projects that management found too compelling to turn down.�

Oi land gas storage tanks.

Image source: Getty Images.

Enterprise Products Partners' results: The raw numbers Metric Q2 2018 Q1 2018 Q2 2017
Gross operating margin $1.48 billion $1.59 billion $1.38 billion
Net income $687 million $912 million $666 million
Diluted EPS $0.31 $0.41 $0.30
Distributable cash flow $1.43 billion $1.39 billion $1.05 billion

DATA SOURCE: ENTERPRISE PRODUCTS PARTNERS EARNINGS RELEASE. EPS = EARNINGS PER SHARE.

For a company that has a reputation as a slow-growing business, Enterprise's growth over the past year or so has been off the charts, with its reported 36% year-over-year jump in distributable cash flow. That increase is a result of several new projects starting commercial operations this past quarter including its propane dehydrogenation (PDH) petrochemical plant, a natural gas processing facility in the Permian Basin, and a natural gas liquids fractionator facility. As these facilities ramp up to full capacity, we should expect even better results.

The one stain on its earnings report was a $322 million, or $0.15 per share, noncash loss related to some crude oil futures contracts. Those mark-to-market�losses, part of fair value accounting practices, are why its crude oil services segment posted a significant decline compared to the prior quarter. Absent those charges, all four of its business segments posted considerable gains.�

EPD gross operating margin by business segment for Q2 2017, Q2 2018, and Q2 2018. Shows sharp decline in crude oil and increases in every other segment.

Data source: Enterprise Products Partners earnings release. Chart by author.

What happened with Enterprise Products Partners this quarter? Total capital expenditures were $983 million for the quarter, which was down slightly compared to the first quarter. That is to be expected, though, as Enterprise brought $1.4 billion in projects into service in the first half of the year. However, management increased its capital spending guidance to�$3.8 billion to $4.0 billion for growth projects, up from�$3.2 to $3.4 billion in the third quarter. The increase in capital spending came after several new project announcements. The most recent string of investments have been heavily weighted toward processing and export facilities, but this past quarter management announced a slew of new projects to expand pipeline capacity for several of its existing projects. It announced a 100,000-barrel-per-day expansion of its Front Range and Texas Express pipelines to deliver growing natural gas liquid production from the Denver-Julesburg�shale basin in Colorado to its storage and petrochemical manufacturing hub in Mont Belvieu, Texas. It intends to reactivate a previously idle natural gas pipe that will deliver from the Barnett shale�formation to a supply hub in Sweeney, Texas. Also, it plans to develop an offshore crude oil export terminal that will be able to fuel Very Large Crude Carriers (VLCCs). Increased distributable cash flow resulted in a distribution coverage ratio of 1.5 times and produced�$491 million in excess cash, which Enterprise intends to use to fund a significant portion of this massive capital spending program over the next 18 months. What management had to say

As part of the company's press release statement, CEO Jim Teague highlighted a couple of the major capital projects recently brought into service and the impact of it had on the bottom line.�

Our PDH facility, which completed commissioning activities and began commercial service in the second quarter, operated at full capacity. The�Midland-to-ECHO crude oil pipeline averaged 545 thousand barrels per day of gross transportation volumes from the�Permian Basin. In total, our liquid pipeline volumes were a record 6.2 million barrels per day and our marine terminal volumes were a record 1.7 million barrels per day.

This operational performance generated record distributable cash flow, excluding proceeds from asset sales, of�$1.4 billion, which provided 1.5 times coverage of our distribution for the quarter. We retained�$491 million�of distributable cash flow to reinvest in the growth of the partnership, which supports our goal of self-funding the equity portion of our growth capital investment.

You can read a full transcript of Enterprise's conference call here.�

EPD Chart

EPD data by YCharts

Ready for the next round

Back at the end of last year, Enterprise's management announced that it was slowing down its distribution growth rate. The aim of the decision was to free up more excess cash to reinvest in the business and become less reliant on issuing equity as a source of funding. This past quarter shows why this was a good decision. The company now has a backlog of construction projects totaling $5.2 billion it expects to complete by the end of 2019. It goes to show the immense investment opportunities in U.S. energy infrastructure over the next several years. With all that retained cash, don't be surprised if we see even more projects get added to the mix over the next several months.

Thursday, August 2, 2018

Brokerages Anticipate Encompass Health Corp (EHC) to Announce $0.83 Earnings Per Share

Wall Street brokerages expect that Encompass Health Corp (NYSE:EHC) will post earnings of $0.83 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for Encompass Health’s earnings. The lowest EPS estimate is $0.82 and the highest is $0.86. Encompass Health posted earnings of $0.71 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 16.9%. The business is expected to announce its next quarterly earnings results after the market closes on Wednesday, July 25th.

On average, analysts expect that Encompass Health will report full year earnings of $3.39 per share for the current financial year, with EPS estimates ranging from $3.36 to $3.45. For the next year, analysts anticipate that the firm will post earnings of $3.65 per share, with EPS estimates ranging from $3.55 to $3.75. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that cover Encompass Health.

Get Encompass Health alerts:

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 26th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.81 by $0.12. Encompass Health had a net margin of 6.76% and a return on equity of 20.76%. The company had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.03 billion.

A number of research analysts have weighed in on the stock. Craig Hallum lifted their price objective on shares of Encompass Health from $63.00 to $71.00 and gave the company a “buy” rating in a report on Monday, April 30th. Royal Bank of Canada lifted their price objective on shares of Encompass Health to $69.00 and gave the company an “outperform” rating in a report on Monday, April 30th. ValuEngine raised shares of Encompass Health from a “buy” rating to a “strong-buy” rating in a report on Friday, April 27th. Robert W. Baird boosted their target price on shares of Encompass Health from $59.00 to $66.00 and gave the stock an “outperform” rating in a research note on Monday, April 30th. Finally, Credit Suisse Group boosted their target price on shares of Encompass Health from $65.00 to $66.00 and gave the stock an “outperform” rating in a research note on Friday, April 27th. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Encompass Health presently has a consensus rating of “Buy” and an average price target of $67.33.

Encompass Health traded down $0.38, reaching $69.87, on Tuesday, according to MarketBeat. The stock had a trading volume of 419,691 shares, compared to its average volume of 1,190,642. Encompass Health has a 12-month low of $42.21 and a 12-month high of $70.43. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.24 and a current ratio of 1.24. The stock has a market capitalization of $6.90 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 1.59 and a beta of 0.35.

The business also recently announced a quarterly dividend, which was paid on Monday, July 16th. Stockholders of record on Monday, July 2nd were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, June 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.43%. Encompass Health’s dividend payout ratio is currently 36.23%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Article: What does RSI mean?

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com